Chemoinformaics analysis of 1-Ethyl-4-methoxy-9H-pyrido[3,4-b]indole
| Molecular Weight | 226.279 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.167 | nRig | 1 |
| Exact Molecular Weight | 226.111 | nRing | 3 |
| Solubility: LogS | -6.856 | nHRing | 2 |
| Solubility: LogP | 8.033 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 35.7171 |
| nHD | 1 | BPOL | 17.4909 |
| QED | 0.259 |
| Synth | 1.705 |
| Natural Product Likeliness | 0.344 |
| NR-PPAR-gamma | 0.403 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.921 |
| MDCK | 0.00000842 |
| BBB | 0.059 |
| PPB | 0.988894 |
| VDSS | 2.48 |
| FU | 0.0127277 |
| CYP1A2-inh | 0.13 |
| CYP1A2-sub | 0.185 |
| CYP2c19-inh | 0.271 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.084 |
| CYP2c9-sub | 0.967 |
| CYP2d6-inh | 0.154 |
| CYP2d6-sub | 0.087 |
| CYP3a4-inh | 0.191 |
| CYP3a4-sub | 0.038 |
| CL | 3.988 |
| T12 | 0.126 |
| hERG | 0.318 |
| Ames | 0.005 |
| ROA | 0.016 |
| SkinSen | 0.951 |
| Carcinogencity | 0.035 |
| EI | 0.915 |
| Respiratory | 0.797 |
| NR-Aromatase | 0.057 |
| Antiviral | Yes |
| Prediction | 0.706466 |